The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Open accessAbstract
BACKGROUND: Psychiatric comorbidity is associated with lower quality of life, more fatigue, and reduced adherence to disease-modifying therapy in multiple sclerosis (MS). OBJECTIVES: The objectives of this review are to estimate the incidence and prevalence of selected comorbid psychiatric disorders in MS and evaluate the quality of included studies. METHODS: We searched the PubMed, PsychInfo, SCOPUS, and Web of Knowledge databases and reference lists of retrieved articles. Abstracts were screened for relevance by two independent reviewers, followed by full-text review. Data were abstracted by one reviewer, and verified by a second reviewer. Study quality was evaluated using a standardized tool. For population-based studies we assessed heterogeneity quantitatively using the I² statistic, and conducted meta-analyses. RESULTS: We included 118 studies in this review. Among population-based studies, the prevalence of anxiety was 21.9% (95% CI: 8.76%-35.0%), while it was 14.8% for alcohol abuse, 5.83% for bipolar disorder, 23.7% (95% CI: 17.4%-30.0%) for depression, 2.5% for substance abuse, and 4.3% (95% CI: 0%-10.3%) for psychosis. CONCLUSION: This review confirms that psychiatric comorbidity, particularly depression and anxiety, is common in MS. However, the incidence of psychiatric comorbidity remains understudied. Future comparisons across studies would be enhanced by developing a consistent approach to measuring psychiatric comorbidity, and reporting of age-, sex-, and ethnicity-specific estimates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A comprehensive systematic review of 118 studies on psychiatric comorbidities in MS found that psychiatric comorbidities were common; in particular, the prevalence of diagnosed anxiety and depression were estimated at 21.9 and 23.7%, respectively [53].”
From Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap (2022) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“MS patients show increased levels of anxiety and depression compared to healthy participants, and these conditions affect more than 20% of patients [8,21,22,23].”
From Biopsychosocial Correlates of Quality of Life in Multiple Sclerosis Patients (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ferrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Marrie, R., Cohen, J., Stüve, O., Trojano, M., Sørensen, P., Reingold, S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis · doi:10.1177/1352458514564491 · Cited by 762
Self-citationNeyeloff, J. L., Fuchs, S. C. P. C., & Moreira, L. B. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-52 · Cited by 731
Depressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J. B., Swartz, E. S., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J. P., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 536
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506
Quality of life in patients with multiple sclerosis
Janardhan, V., & Bakshi, R. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00312-x · Cited by 489
Lobentanz, I. S., Asenbaum, S., Vass, K., Sauter, C., Klosch, G., Kollegger, H., Kristoferitsch, W., & Zeitlhofer, J. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00257.x · Cited by 439
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424
Cited by
Sorted by citations
Items 301–400 of 519
Shenoy, N., Liu, F., & Narayanan, S. P. (2024) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2307129 · Cited by 5
Marrie, R. A., Kosowan, L., Taylor, C. R., & Singer, A. G. (2019) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217319894360 · Cited by 5
Self-citationHassan, T. A., Elkholy, S. F., Shehata, H., Shalaby, N., Elmazny, A. N., Sadek, M. N., Mahmoud, B. E., & Elsherbiny, M. M. (2021) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-020-00404-x · Cited by 5
Factors Associated with Depression and Anxiety Severity in Multiple Sclerosis Patients
Seferoğlu, M., Koca, N., Sıvacı, A. Ö., & Yurtoğulları, Ş. (2021) · Journal of Multiple Sclerosis Research · doi:10.4274/jmsr.galenos.2022.2021-10-2 · Cited by 7
Amiri, Z., Azmin, M., Amiri, S., Akbarisari, A., Sahraian, M. A., Farzadfar, F., & Soleymani, F. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104693 · Cited by 5
Prevalence of fibromyalgia in a Brazilian series of patients with multiple sclerosis
Thomas, C., Schneider, B. T., Verza, C. S., Fassina, G. S., Weber, L. R., Moreira, M., Fusinato, P. T., & Forcelini, C. M. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1772673 · Cited by 5
Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis
Zahoor, I., Pan, G., Cerghet, M., ElBayoumi, T. A., Mao‐Draayer, Y., Giri, S., & Palaniyandi, S. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35753 · Cited by 6
Fatigue and depression influence the prevalence of anxiety in patients with multiple sclerosis
Nyári, A., Kokas, Z., Szamosi, S., Fricska‐Nagy, Z., Kincses, Z. T., Füvesi, J., Biernacki, T., Klivènyi, P., Bencsik, K., & Sandi, D. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07737-9 · Cited by 6
Ytterberg, C., Chruzander, C., Backenroth, G., Kierkegaard, M., Ahlström, G., & Gottberg, K. (2017) · International Journal of Qualitative Studies on Health and Well-Being · doi:10.1080/17482631.2017.1325673 · Cited by 6
Effectiveness of Unity-Oriented Psychodrama on Sense of Coherence of MS Patients
Dehnavi, S., Mohammadi, A. Z., & Hassaniraad, M. (2018) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.5869 · Cited by 5
Gromisch, E. S., Kulas, J. F., Altalib, H. H., Kerns, R. D., Mattocks, K. M., Brandt, C., & Haskell, S. G. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102220 · Cited by 6
Correlates of the personality change judgments of individuals who have MS
Weddell, R., & Fisher-Hicks, S. (2021) · Brain Injury · doi:10.1080/02699052.2020.1865568 · Cited by 5
Khatri, I. A., Aljwair, S., Alammar, H., Altariq, A., Masud, N., Malik, Y. M. A., & Kojan, S. M. (2021) · Cureus · doi:10.7759/cureus.13619 · Cited by 5
Jones, C. D., Jeng, B., Šilić, P., & Motl, R. W. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103889 · Cited by 5
Hu, Z., Fu, Y., Wang, J., Li, Y., & Jiang, Q. (2023) · Oncology Letters · doi:10.3892/ol.2023.13669 · Cited by 5
Auer, M., Hegen, H., Luft, T., Bsteh, G., Fogdell‐Hahn, A., Loercher, A. E., & Deisenhammer, F. (2016) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0054 · Cited by 5
Neurobehavioral Aspects of Different Forms of Multiple Sclerosis
Oudia, N. B. A. N. (2015) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000293 · Cited by 5
Gateway reflex: Local neuroimmune interactions that regulate blood vessels
Kamimura, D., Ohki, T., Arima, Y., Ota, M., & Murakami, M. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.09.011 · Cited by 6
Öz, H. S. (2019) · Journal of Psychiatric Nursing · doi:10.14744/phd.2019.19970 · Cited by 5
Morrison, E., Sorkin, D. H., Mosqueda, L. A., & Ayutyanont, N. (2021) · International Journal of MS Care · doi:10.7224/1537-2073.2020-016 · Cited by 4
Cognitive behavioural therapy for neurologists
Stanton, B. R., Chalder, T., & Carvalho, C. (2023) · Practical Neurology · doi:10.1136/pn-2023-003857 · Cited by 4
Vicente-Escudero, J. L. (2025) · Journal of Technology in Behavioral Science · doi:10.1007/s41347-025-00488-0 · Cited by 4
Brain FADE syndrome: the final common pathway of chronic inflammation in neurological disease
Hanafy, K. A., & Jovin, T. G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1332776 · Cited by 4
GUBSKAIA, K. V., Malygin, Y. V., & Aleksandrova, A. Y. (2024) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2024-2s-11-17 · Cited by 4
Keenan, A., Whichello, C. L., Le, H. H., Kern, D. M., Fernandez, G. S., Turner, V., Das, A., Quaife, M., & Ross, A. P. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00510-w · Cited by 4
Helminen, J., & Jehkonen, M. (2024) · Applied Neuropsychology Adult · doi:10.1080/23279095.2024.2403764 · Cited by 4
Les maladies neurologiques à expression psychiatrique : importance de l’examen neurologique
Haroche, A., Amad, A., Fovet, T., Geoffroy, P., & Defebvre, L. (2017) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2017.03.004 · Cited by 7
Naseri, A., Nasiri, E., Talebi, M., Karimi, K., & Talebi, M. (2020) · Romanian Journal of Neurology · doi:10.37897/rjn.2020.3.6 · Cited by 5
Refaie, E., García, S. G., Martínez‐Domínguez, S. J., Gargallo-Puyuelo, C. J., Quilez, L. L., Carrera‐Lasfuentes, P., Arroyo, M., & García, F. G. (2021) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2021.03.012 · Cited by 4
The Impact of COVID-19 on the Lives of Individuals With Multiple Sclerosis: 1 Year Into the Pandemic
LYNCH, S. G., Baker, S., Hunt, S. L., Thuringer, A., Jassam, Y. N., & Bruce, J. M. (2022) · International Journal of MS Care · doi:10.7224/1537-2073.2021-099 · Cited by 4
Bahramian, A., Shabani, A., Naserbakht, M., & Hadi, F. (2023) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.37.4 · Cited by 4
Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort
Uzochukwu, E., Harding, K. E., Hrastelj, J., Kreft, K. L., Holmans, P., Jones, L., Robertson, N. P., Tallantyre, E. C., & Lawton, M. (2024) · Neuroepidemiology · doi:10.1159/000536427 · Cited by 4
Inflammation and Depression in Patients With Autoimmune Disease, Diabetes, and Obesity
Gregory, J. M., Mak, M. S. B., & McIntyre, R. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00021-0 · Cited by 5
Eibner, C., Vardavas, R., Nowak, S. A., Liu, J., & Rao, P. (2019) · RAND Corporation eBooks · doi:10.7249/rr4246 · Cited by 4
A short-term exercise program in patients with multiple sclerosis: is body mass index important?
Yığman, Z. A., Karaahmet, Ö. Z., Ertürk, F. A., & Yığman, F. (2021) · International Journal of Rehabilitation Research · doi:10.1097/mrr.0000000000000462 · Cited by 4
Multiple sclerosis in First Nations Canadians: A pilot comparison study
Marrie, R. A., Hall, N., & Sadovnick, A. D. (2016) · Multiple Sclerosis Journal - Experimental Translational and Clinical · doi:10.1177/2055217316666093 · Cited by 4
Self-citationPsychotherapy in Neurorehabilitation
Schmidt, R., Piliavska, K., Maier-Ring, D., van Husen, D. K., & Dettmers, C. (2017) · Neurology International Open · doi:10.1055/s-0043-104643 · Cited by 5
Smoking is not associated with higher prevalence of JC virus in MS patients
Auer, M., Bsteh, G., Hegen, H., Pauli, F. D., Wurth, S., Berger, T., & Deisenhammer, F. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3204-z · Cited by 4
Anxiety and Cognition in Multiple Sclerosis: A Narrative Review
Susini, R. M., Ciufia, N., Marinangeli, A., Alonso, R. N., & Eizaguirre, M. B. (2025) · International Journal of MS Care · doi:10.7224/1537-2073.2024-037 · Cited by 5
Tang, A., Brooks, L., Boudreau, D. M., Chanu, P., Joshi, A., Vora, B., & Zhu, R. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3652 · Cited by 3
Cognitive reserve in multiple sclerosis: The role of depression and fatigue
Stein, C., O’Keeffe, F. M., Brosnan, M. B., Flynn, C., McGuigan, C., & Bramham, J. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251338757 · Cited by 3
Yoga in autoimmune disorders: a systematic review of randomized controlled trials
Baishya, A., Sharma, S., Hazarika, D., Saini, S., Sharma, H. K., & Metri, K. (2025) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaf049 · Cited by 3
Kılıç, Ö., Çelik, R. G. G., Emül, M., Saip, S., Altıntaş, A., & Sıva, A. (2022) · Çukurova medical journal (Online)/Çukurova medical journal · doi:10.17826/cumj.1147756 · Cited by 3
Göçmen, A., & Ethemoğlu, Ö. (2023) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2023.107888 · Cited by 4
At home e-based physical exercise programs in patients with multiple sclerosis: a scoping review
Adnan, R., Roikjær, S. G., Samadzadeh, S., Richter, C. J., Weinshenker, B. G., Paul, F., Skou, S. T., Dalgas, U., & Asgari, N. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1449519 · Cited by 7
Phillips, B., Morrow, S. A., Singh, H., Oh, J., Kolind, S., Lynd, L. D., Prat, A., Tam, R. C., Traboulsee, A. L., & Patten, S. B. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106761 · Cited by 3
Does the presence of multiple sclerosis impact on symptom profile in depressed patients?
Boeschoten, R., Schaakxs, R., Dekker, J., Uitdehaag, B., Beekman, A., Smit, J., Penninx, B., & van Oppen, P. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.10.006 · Cited by 3
Mental symptoms in MS (MeSyMS): Development and validation of a new assessment
Filser, M., Baetge, S. J., Balloff, C., Buchner, A., Fink, G. R., Heibel, M., Meier, U., Rau, D., Renner, A., Schreiber, H., et al. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102744 · Cited by 3
Clinical advances in multiple sclerosis and amyotrophic lateral sclerosis treatment: A review
Zerecero-Morcksharpe, M., & García, E. (2021) · Proceedings of Scientific Research Universidad Anáhuac Multidisciplinary Journal of Healthcare · doi:10.36105/psrua.2021v1n2.06 · Cited by 3
Özer, D., Ata, E. E., Dıkeç, G., & Demir, S. (2022) · Contemporary Nurse · doi:10.1080/10376178.2022.2107037 · Cited by 3
Weigel, M., Hutchinson, B., Magee, W. L., Leong, K., Sweitzer, T., Weiss, J. L., Su, W. W., & Fleming, R. (2023) · International Journal of MS Care · doi:10.7224/1537-2073.2021-144 · Cited by 3
Šilić, P., Jeng, B., Jones, C. D., Huynh, T. L. T., Duffecy, J. L., & Motl, R. W. (2023) · Mental health and physical activity · doi:10.1016/j.mhpa.2023.100541 · Cited by 6
Fragkiadaki, E., Cotterill, N., Rice, C. M., Smith, J. A., & Nizza, I. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288295 · Cited by 5
Mado, H., Błachut, M. K., Szczegielniak, A. R., Świerzy, K., Zając, M., Kubicka, K., Gorczyca, P. W., & Adamczyk-Sowa, M. H. (2024) · Medicina · doi:10.3390/medicina60030376 · Cited by 3
Study protocol: exercise training for treating major depressive disorder in multiple sclerosis
Motl, R. W., Bombardier, C. H., Duffecy, J. L., Hibner, B. A., Wathen, A., Carrithers, M. D., & Cutter, G. (2024) · BMC Neurology · doi:10.1186/s12883-024-03634-y · Cited by 3
Self-citationDettmers, C., Henze, T., & Schmidt, R. (2024) · Springer eBooks · doi:10.1007/978-3-662-66957-0_32 · Cited by 3
Bettcher, B. M., Bevan, C. J., & Geschwind, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00041-x · Cited by 3
Ferreri, F., Bourla, A., Capron, J., Quillerou, B., Rossignol, J., Borden, A., Guechot, J., Lamazière, A., Nuss, P., MEKINIAN, A., et al. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.04.017 · Cited by 3
Eşkut, N., Ataç, C., Köşkderelioğlu, A., & Ünsal, Y. Ö. (2021) · OSMANGAZİ JOURNAL OF MEDICINE · doi:10.20515/otd.948805 · Cited by 3
Candiri, B., Ramazanoğlu, E., Talu, B., & Tecellioğlu, M. (2024) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0044-1788273 · Cited by 3
Silveira, S. L., Beydoun, H. A., & Tsai, J. (2024) · CNS Spectrums · doi:10.1017/s1092852924002165 · Cited by 2
Infortuna, C., Buccafusca, M., Graceffa, A. M. S., Maiorana, E., Wang, R., Ganesh, S., Yedidia, O., Bruno, A., Iannuzzo, F., Thomas, F. P., et al. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1561995 · Cited by 2
Physiotherapy management of multiple sclerosis
Learmonth, Y. C. (2025) · Journal of physiotherapy · doi:10.1016/j.jphys.2025.11.008 · Cited by 2
Epigenetics and multiple sclerosis
Kular, L., Castelo‐Branco, G., & Jagodic, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800226-1.00010-1 · Cited by 2
Yıldırım, A. (2020) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.14744/dajpns.2019.00058 · Cited by 3
Prevalence of depression among patients with multiple sclerosis in Erbil city
Sulaiman, W., & Ali, S. (2020) · Zanco Journal of Medical Sciences · doi:10.15218/zjms.2020.029 · Cited by 1
Medical cannabis in multiple sclerosis
Erridge, S., Sodergren, M. H., & Weatherall, M. W. (2022) · British Journal of Neuroscience Nursing · doi:10.12968/bjnn.2022.18.sup3.s28 · Cited by 2
The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia
Alshammari, A. N., Alshammari, K. A., Alshammari, S. N., Aldhaifi, S. Y., & Alqahtani, A. (2023) · Neurosciences · doi:10.17712/nsj.2023.2.20110104 · Cited by 2
Yousefi, F., Kamyab, P., Fakhraei, B., Farjam, M., Rezaei, S., Mahmoudi, S. S., Moghadm, Z. K., Tabrizi, R., & Jafari, N. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.3153 · Cited by 2
Martin, S., Kihlbom, U., Pasquini, G., Gerli, F., Niccolai, C., Bella, S. D., Portaccio, E., Betti, M., Amato, M. P., Achiron, A., et al. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.106143 · Cited by 2
Psychoses in Pediatric‐Onset Multiple Sclerosis: A Case Report and Systematic Review
Ellouz, E., Ketata, I., Abbes, W., Gargouri, H., & Bader, S. (2024) · Journal of Child and Adolescent Psychiatric Nursing · doi:10.1111/jcap.70005 · Cited by 3
Незнанов, Н. Г., Tanashyan, M. M., Akarachkova, E. S., Amelin, A. V., Bogolepova, A. N., Vasileva, A. V., Ермоленко, Н. А., Zakharov, V. V., Лебедева, А. В., Maksimova, M. Y., et al. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2024124121126 · Cited by 2
Silveira, S. L., Deemer, S. E., & Synkowski, E. (2025) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2025.06.009 · Cited by 2
Borovčanin, M., Milovanović, M., Vesić, K., Muric, N. N., Milovanović, J., Arsenijević, A., & Arsenijević, N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85415-3.00011-8 · Cited by 2
Immunological changes following electroconvulsive therapy in multiple sclerosis
Kavakbasi, E., Rodner, F., Nimalavachchlan, L., Schwarte, K., Schettler, C., Bonnekoh, L. M., Opel, N., Peine, A.-C., Baune, B. T., & Hohoff, C. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.03.061 · Cited by 2
Bombardier, C. H. (2024) · doi:10.1093/oso/9780197748268.003.0009 · Cited by 2
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course
Conway, D. S., Sullivan, A. B., & Rensel, M. R. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.06.007 · Cited by 2
Yue, H., Shah, S. B., Modzelewski, K. L., Knobel, M., Copeli, F., & Kao, L. E. (2023) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000378 · Cited by 2
Naseri, A., Nasiri, E., Talebi, M., & Talebi, M. (2021) · Eastern Mediterranean Health Journal · doi:10.26719/emhj.21.034 · Cited by 2
Comorbidities in MS are associated with treatment intolerance and disability
McDonnell, G. V., & Cohen, J. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004699 · Cited by 2
Self-citationPrevalence of psychiatric disorders among patients with Multiple Sclerosis: a cross-sectional study.Preprint
Błachut, M. K., Szczegielniak, A. R., Świerzy, K., Tarska, M. Z., Kubicka, K., Adamczyk-Sowa, M. H., & Gorczyca, P. W. (2020) · doi:10.21203/rs.3.rs-24149/v1 · Cited by 2
Mental symptoms in patients who suffer from multiple sclerosis
Machová, Š., & Kadlecová, E. (2018) · Psychiatrie pro praxi · doi:10.36290/psy.2018.022 · Cited by 1
Autoimmune comorbidities in persons with multiple sclerosis in the population of Belgrade
Maric, G. D., Tamaš, O., Jovanović, A., Veselinović, N., Ivanović, J., Jovičević, V., Andabaka, M., Ilić, M., Mesaroš, Š., Pekmezovic, T. D., et al. (2022) · Medicinska istrazivanja · doi:10.5937/medi55-39621 · Cited by 1
Reyes-Méndez, C., Gómez-Bautista, D., Yáñez-Téllez, G., Rodríguez-Chávez, E., & Moreno-Villagómez, J. (2024) · The Clinical Neuropsychologist · doi:10.1080/13854046.2024.2370963 · Cited by 1
Health-Related Quality of Life among Patients with Multiple Sclerosis
Jowair, S. A. B., Onazi, M. O. A., Hoti, W. I. A., Otaibi, R. B. A., Nasser, M. A. A., Jower, S. Z. A., Onazi, M. O. A., & Anazi, B. A. (2025) · European Journal of Medical and Health Research · doi:10.59324/ejmhr.2025.3(1).10 · Cited by 1
Diamond, K., Ruane, R., Dawes, C., Byrne, S., Taha, M., Foo, A. C. M., Mowszowski, L., Beadnall, H. N., Garber, J., Po, K., et al. (2025) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2025.106464 · Cited by 2
Ocrelizumab's Place in the Therapeutic Landscape at its 2019 Launch in France
Mercier, G., Pau, D., Bourel, G., Belhassen, M., Deygas, F., Marchal, C., Larrieu, S., Civet, A., & Moisset, X. (2025) · Journal of Multiple Sclerosis and Neuroimmunology · doi:10.59578/jmsni.2025.16.1.19-25 · Cited by 1
Biasi, M. M., Taurisano, P., Manni, A., Mangialardi, V., Gasparre, D., Iaffaldano, P., Caputo, F., Iaffaldano, A., & Paolicelli, D. (2025) · BMC Psychology · doi:10.1186/s40359-025-03162-5 · Cited by 1
Šilić, P., Kidwell-Chandler, A. L., & Motl, R. W. (2025) · Mental health and physical activity · doi:10.1016/j.mhpa.2025.100720 · Cited by 2
Leung, M. W. Y., van de Garde, E. M. W., Uitdehaag, B. M. J., Souverein, P. C., Klungel, O. H., & Bazelier, M. T. (2025) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.70260 · Cited by 1
Grech, L., Allan, M., Edward, K., Giles, A., Kulkarni, J., Rajendran, D., Shaw, S., Neil, J., Caswell, N., Fanning, V., et al. (2026) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2025.2607146 · Cited by 1
Alaboson, J., Coffey, L., & Maguire, R. (2026) · Journal of Health Psychology · doi:10.1177/13591053251392873 · Cited by 1
Kim, N., Stuifbergen, A. M., Becker, H., Swift‐Scanlan, T., Osier, N. S., & Buxhoeveden, S. (2026) · Western Journal of Nursing Research · doi:10.1177/01939459251405618 · Cited by 1
Inflammatory models of depression in rodents and humans
Markov, D., Zozulya, S. A., & Dolotov, O. V. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1687579 · Cited by 5
Takla, T. N., Monaghan, P. G., Abbawi, M. M., Landers, M. R., Marusak, H. A., Daugherty, A. M., & Fritz, N. E. (2026) · Neurorehabilitation and neural repair · doi:10.1177/15459683251412284 · Cited by 1
Cognitively stimulating activities in multiple sclerosis: Results of a randomized controlled trial
Færk, A. K., Sellebjerg, F. T., Lund, J. L., Loft, M., Chow, H. H., & Marstrand, L. (2026) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2026.107282 · Cited by 1
Mirmosayyeb, O., Aghajanian, S., Vaheb, S., Mohammadifard, F., Sharbafchi, M. R., & Shaygannejad, V. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08310-8 · Cited by 1
Post-traumatic stress disorder in people with multiple sclerosis: A narrative review
Freedman, D., Oh, J., & Feinstein, A. (2026) · Multiple Sclerosis Journal · doi:10.1177/13524585261475088 · Cited by 1
Yokoyama, K., & Hattori, N. (2015) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12277 · Cited by 1
Effects of comorbidity in persons with multiple sclerosis
Maric, G. D., Pekmezovic, T. D., Lalic, K. S., Mesaroš, Š., & Drulovic, J. S. (2019) · Medicinski podmladak · doi:10.5937/mp70-21909 · Cited by 1
Metadata
- Authors
- Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N.
- Affiliations
- University of Manitoba (CA)
- Scientific and Clinical Review Associates, LLC, USA
- Cleveland Clinic (US)
- Department of Neurology and Neurotherapeutics, University of Texas Southwestern, USA
- Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, Italy
- Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
- University of Alabama at Birmingham (US)
- Corresponding author
- Marrie, Ruth Ann
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2015-01-12
- Volume
- 21
- Issue
- 3
- Pages
- 305-317
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- PMC
- PMC4429164
- OpenAlex
- W2105913548
- Cited by
- 519
- References
- 136
- Citations by year
- 2026: 42 · 2025: 31 · 2024: 45 · 2023: 46 · 2022: 52 · 2021: 68 · 2020: 48 · 2019: 38 · 2018: 43 · 2017: 47 · 2016: 43 · 2015: 16
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Multiple Sclerosis Journal (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- mediaTUM (Technical University of Munich) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- Funders
- U.S. Department of Defense
- National Multiple Sclerosis Society
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- Cleveland Clinic
- Multiple Sclerosis Society of Canada
- Multiple Sclerosis Society
- MedDay Pharmaceuticals
- National Institutes of Health
- Genentech
- EMD Serono
- National Heart, Lung, and Blood Institute
- National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Keywords
- multiple sclerosis, psychiatric comorbidity, depression, anxiety, alcohol abuse, bipolar disorder, substance abuse, psychosis, incidence, prevalence, quality of life, fatigue
- MeSH terms
- Mental Disorders, Humans, Multiple Sclerosis, Comorbidity, Incidence, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
